News Focus
News Focus
icon url

Zeev Hed

07/09/02 2:19 PM

#1062 RE: Paul Moerman #1059

I'll see how it behave in the next ramp, but the last indication I have is that NOVN is going to report excellent results (their own update, and who believe Corporate America now aday?). The stop should be about half a buck under todays low.

Zeev

icon url

Alex G

07/09/02 2:32 PM

#1069 RE: Paul Moerman #1059

re: NOVN... It is down on the same news as Wyeth, really not too hard to find-

Wyeth- "...government researchers halted a study of the drugmaker's Prempro hormone replacement treatment on concern it may raise patients' risk of breast cancer and heart disease."

"Shares of other makers of hormone therapies, including Noven Pharmaceuticals Inc. and Novavax Inc., also fell..."

"Shares of Noven, which makes patches that deliver hormones through the skin, fell $5.60, or 27 percent, to $14.99. Noven is the only company that makes a patch, called CombiPatch, that combines estrogen and progestin..."